In ER+ breast cancer, YAP acts as a mechanosensitive transcriptional co-regulator that links extracellular mechanical cues to changes in ER signaling, cytoskeletal organization and cell-cycle control. This evidence concerns the gene YAP1 and breast carcinoma.